Biotech Values

[PharmaRx]

http://pharminvest.blogspot.com/2011/04/biologics-patent-expiry.html?spref=bl" rel="nofollow" target="_blank" >[/url][tag]insert-text-here[/tag][url]http://pharminvest.blogspot.com/2011/04/biologics-patent-expiry.html?spref=bl[tag] The global biologics market is valued at an estimated $149 billion in 2010 Monoclonal antibodies (mAbs) comprised 31.9% of the 2009 market, or $43 billion. The mAb segment is expected to increase at the fastest rate within the total biologics market to $86 billion by 2015, from a value of $48 billion in 2010, a compound annual growth rate (CAGR) of 12.4%.

- Therapeutic proteins were nearly half the 2009 market, or 48.8%, and the largest segment at $66 billion. The therapeutic protein segment is valued at $72 billion in 2010 and expected to increase at an 8.2% a compound annual growth rate (CAGR) to reach $107 billion in 2015.

[/tag]